|
SYPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.180730E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.185550E-04 |
| Normal-vs-Stage2 |
2.436000E-03 |
| Normal-vs-Stage3 |
2.779000E-04 |
| Normal-vs-Stage4 |
9.322700E-03 |
| Stage1-vs-Stage2 |
8.889800E-01 |
| Stage1-vs-Stage3 |
5.077800E-01 |
| Stage1-vs-Stage4 |
9.872000E-01 |
| Stage2-vs-Stage3 |
7.231000E-01 |
| Stage2-vs-Stage4 |
9.141200E-01 |
| Stage3-vs-Stage4 |
6.812400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.5504000000004E-05 |
| Normal-vs-AfricanAmerican |
8.794600E-04 |
| Normal-vs-Asian |
1.800550E-01 |
| Caucasian-vs-AfricanAmerican |
8.857600E-01 |
| Caucasian-vs-Asian |
7.460000E-01 |
| AfricanAmerican-vs-Asian |
6.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.11399999999951E-05 |
| Normal-vs-Female |
4.666100E-02 |
| Male-vs-Female |
3.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.062900E-03 |
| Normal-vs-Extreme_Weight |
2.752200E-04 |
| Normal-vs-Obese |
2.788400E-04 |
| Normal-vs-Extreme_Obese |
6.452400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.097600E-01 |
| Normal_Weight-vs-Obese |
8.286000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.681400E-01 |
| Extreme_Weight-vs-Obese |
8.290800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.434400E-01 |
| Obese-vs-Extreme_Obese |
8.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.581000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.024000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.08080000002808E-06 |
| Normal-vs-Age(81-100Yrs) |
3.455000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.255800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.825000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.348800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.208830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.458400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.820800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.756880E-03 |
| Normal-VS-Type2 PRCC |
2.00360000000011E-05 |
| Normal-VS-KIRP CIMP |
5.833700E-04 |
| Normal-VS-Unclassified PRCC |
6.035900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.855600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.018400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.867000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.137200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.907600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.185400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76952999999536E-05 |
| Normal-vs-N1 |
8.47270000000622E-05 |
| Normal-vs-N2 |
1.942160E-02 |
| N0-vs-N1 |
9.066800E-01 |
| N0-vs-N2 |
9.066200E-01 |
| N1-vs-N2 |
9.455200E-01 |
|
|
